Atlas Venture

Atlas Venture is a leading biotech venture capital firm.  Atlas companies are custom built to realize their scientific and business potential.

DISCOVER: Identifying true innovation from high-impact science.

DERISK: Proving and maturing the science and technology to guide clinical translation

SHAPE: Crafting the right business model for each opportunity.

STRENGTHEN: Rolling up our sleeves to position our companies for successful drug development and exits in all market environments.

HQCambridge, MA, US
Cybersecurity ratingAMore
Atlas Venture was founded in 1984 and is headquartered in Cambridge, MA, US

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Atlas Venture

Kevin Bitterman

Kevin Bitterman

Bruce Booth

Bruce Booth

Jason Rhodes

Jason Rhodes

Jean-Francois Formela

Jean-Francois Formela

David Grayzel

David Grayzel

Michael Gladstone

Michael Gladstone

Show more

Atlas Venture Office Locations

Atlas Venture has an office in Cambridge
Cambridge, MA, US (HQ)
400 Technology Square, 400 Technology Square
Show all (1)

Atlas Venture Investment Portfolio

Stage Distribution


Top Sectors Distribution


Round Size Distribution

Show more

Atlas Venture News and Updates

Akrevia Therapeutics Launches with $30M Series A Financing Led by F-Prime Capital Partners and Atlas Venture

CAMBRIDGE, Mass., Sept. 27, 2018 /PRNewswire/ -- Akrevia Therapeutics, a privately-held biopharmaceutical company focused on developing highly-potent, tumor-targeted immuno-oncology therapeutics, today announced the closing of a $30 million Series A financing led by F-Prime Capital...

Atlas Venture wraps up 11th fund at $350 mln

Cambridge, Massachusetts-based Atlas Venture, an early-stage venture firm, has closed its oversubscribed 11th fund at $350 million. Altas Ventures invests in biotech startups.

Atlas Venture Online and Social Media Presence

Embed Graph

Atlas Venture Blogs

A Firsthand Covid Perspective

“You did nothing wrong,” said the Department of Public Health contact tracer who called my spouse late on January 2nd, “you wore a mask and followed all the safety guidelines. We may never know ultimately how you got it.” The sentiment brought no relief – our whole family, myself included, now have …

The Biotech Paradox of 2020: A Year In Review

2020 was an incredibly paradoxical year for those of us in biotech: the striking dichotomy of simultaneously experiencing agonizing tragedy alongside buoyant optimism. Read more. The post The Biotech Paradox of 2020: A Year In Review appeared first on Atlas Venture.

Atlas Venture’s 2020 Year in Review

A look back at 2020 and to the future at Atlas Venture. View the newsletter. The post Atlas Venture’s 2020 Year in Review appeared first on Atlas Venture.

Novartis snaps up neuro partner Cadent for $210M upfront with promise of up to $560M more

Novartis teamed up with Cadent Therapeutics on treatment-resistant depression back when the neuro-focused biotech was working under the radar. Five years later, the Swiss pharma is helping itself to the rest of Cadent’s pipeline in a deal worth $210 million upfront but that could net the latter up t…

GlaxoSmithKline plumbs the discovery field (again), betting up to $815M for the latest add-on to its oncology pipeline

Five years after Novartis stepped up with a sizable deal that gave them worldwide rights to Surface Oncology’s lead cancer drug, GlaxoSmithKline is coming in at the other end of the pipeline, snagging a preclinical natural killer drug designed to whip up a more effective attack on cancer cells. Read…

Beyond The Balance Sheet: Thinking Broadly About Dilution In Building A Transformative Biotech

Over the course of my career in healthcare, I’ve been fortunate to serve in a leadership role through four IPOs and even more financing rounds. All told, I’ve raised well over $1.5 billion in capital. That means I’ve spent a lot of time thinking about dilution. By Joshua Brumm, CEO of Dyne Therapeut…
Show more

Atlas Venture Frequently Asked Questions

  • When was Atlas Venture founded?

    Atlas Venture was founded in 1984.

  • Who are Atlas Venture key executives?

    Atlas Venture's key executives are Kevin Bitterman, Bruce Booth and Jason Rhodes.

  • Where is Atlas Venture headquarters?

    Atlas Venture headquarters is located at 400 Technology Square, 400 Technology Square, Cambridge.

  • Where are Atlas Venture offices?

    Atlas Venture has an office in Cambridge.

  • How many offices does Atlas Venture have?

    Atlas Venture has 1 office.